Navigation Links
Immunosyn Corporation Releases SF-1019 Study Results
Date:11/8/2007

LA JOLLA, Calif., Nov. 8 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) releases the SF-1019 Compassionate Provisional Studies Summary (CFR 312.36).

The Institute of Biologic Research (IBR) was engaged by Argyll Biotechnologies, LLC, Immunosyn's largest shareholder, to conduct limited feasibility clinical studies of SF-1019 on several progressive neurological auto-immune and inflammatory conditions for which there was no satisfactory form of therapy. The studies were performed with the approval of and under the supervision of Research Consultants International and the RBIIRB Institutional Review Board.

Conditions chosen for investigational review included but were not limited to Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy (RSD or RSDS).

The summary presented by IBR states that after complete medical evaluation, a small cohort of patients was chosen for the initial study and the results were extraordinary. Neurological scores on average were elevated from 52.5 before SF-1019 to 74.2 after therapy with SF-1019. The improvement was statistically significant at P 001 level. Comprehensive metabolic profile and complete blood counts were observed to be normal before and after injections of SF-1019.

According to the results, specific measurable improvements within 10-20 minutes were apparent in tremor, numbness, motor strength, walking, balance, speech, pain and coordination. Within 24 hours and continued with each subsequent weekly injection there was an increase in motor strength, lessening of fatigue, walking, alleviation of numbness and pain, coordination and, in one patient, a measurable reversal of osteoporosis.

"Although preliminary, the results were extraordinary. It appears that SF-1019 is safe and effective as a single form of therapy for treatment of progressive neurological auto-immune and inflammatory conditions for which there is no other satisfactor
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 04, 2015 ... announced the addition of the "Investigation ... report to their offering. ... repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a ... matrix, sodium hyaluronate can lubricate the joint, ...
(Date:9/3/2015)... Report Details What can be expected from ... grow at the fastest rates? Visiongain,s brand new report ... opportunities and prospects there. Our 205-page report ... lucrative areas in the industry and the future market ... at overall world market and regional level. You will ...
(Date:9/3/2015)... NEW YORK , Sept. 3,  2015 ... organs are human-made bio-artificial devices, which are ... or support natural organs. These include artificial ... materials such as polymers (polyurethane, polysulfone, and ... used to develop artificial organs. These organs ...
Breaking Medicine Technology:Investigation Report on China's Sodium Hyaluronate Market 2015 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Global Artificial Organ Market 2015-2019 2
... At the ARPA-E Energy Innovation Summit today in ... will announce significant progress towards developing economical, commercial scale ... plants.  The program is supported by an ARPA-E Recovery ... of carbon dioxide, a significant greenhouse gas. ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... for 2011 and beyond and declared that the four quarterly dividends ... per share of common stock.  The $0.15 dividends will be paid ... all stockholders who own shares of PDL on March 8, June ...
Cached Medicine Technology:Codexis Announces Carbon Capture Progress at ARPA-E Summit 2Codexis Announces Carbon Capture Progress at ARPA-E Summit 3PDL BioPharma Announces Regular Quarterly Dividend Policy 2
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published ... Dental Association presented data showing that it is safe for pregnant women to undergo ... that had undergone local anesthesia with a group that hadn’t, researchers were able to ...
(Date:9/4/2015)... ... , ... With TransCel from Pixel Film Studios users can simulate celluloid media ... TransCel users have full control over camera position and angle within 3D space from ... color, text, and more. With TransCel the possibilities are endless. , Users have full ...
(Date:9/4/2015)... Diego, California (PRWEB) , ... September 04, 2015 , ... ... on behalf of Tanya De La Paz. , Schmidt National Law Group, a ... the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one ... New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to learn ... at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM ...
(Date:9/4/2015)... ... 2015 , ... After wearing the same uniforms for six seasons, the Sprayberry ... effort to assist the team, the Jones Agency, a locally owned insurance firm that ... for the new uniforms. , As is so often the case with high school ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3
... four specialist trainee doctors in England views their future ... result of changes in training and healthcare delivery, //reveals ... edition of Postgraduate Medical Journal. ,While the ... for long term conditions, away from hospitals into the ...
... have announced the discovery of another gene responsible for ... of the disease (occurring in around 90 percent of ... from Boston University, the University of Toronto, and Columbia ... published in Nature Genetics. ,The reasearchers ...
... use of oral chemotherapy in US cancer centres need to ... ,Common malignancies can be treated with oral chemotherapy ... and internationally. ,Researchers from Boston set out ... centres for the provision of oral chemotherapy. Forty-two centres took ...
... team works on understanding the heart's natural electrical ... Electrophysiology Lab, //she is a faculty member in ... rhythms, pulses and patterns of the human heart ... millennia, yet the heart's deepest secrets remain tightly ...
... injured athlete can rest on the couch to recover before ... same luxury – at least not yet. // ,One ... years, mechanical support devices for the heart will be put ... and recover itself. Right now, such heart pumps, known commonly ...
... The definition of a ‘healthy’ amount of sun exposure may ... ,Exposure to the sun is needed for the ... bone health and may also be important for prevention of ... they attempt to strike a balance between keeping out of ...
Cached Medicine News:Health News:One in Four Specialist Trainee Doctors 'Very Worried' About Future Job Prospects 2Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2Health News:Secrets of the Heart's Signals 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Safe Sun Exposure a Burning Issue 2
... do the exams you want: ,Four probe choices, ... easiest water path probe in the industry, gives ... what you need to. From full sulcus-to-sulcus ... the P60 provides the clarity of images and ...
... Aspheric Lens System can revolutionize your ... your cataract patients will want for ... contrast sensitivity. With a revolutionary aberration-free ... deliver superior optical performance to a ...
... comprehensive neurological monitoring in the operating ... accurately access your patients neurological status. ... experience, and a long history of ... systems have a proven record of ...
Designed to meet the demanding requirements of scientific and laboratory,applications. Special cabinet incorporates industrial quality with a,heavy duty refrigeration system to maintain your valu...
Medicine Products: